<DOC>
	<DOCNO>NCT00002171</DOCNO>
	<brief_summary>The purpose study see safe effective give Viracept plus stavudine ( d4T ) plus lamivudine ( 3TC ) HIV-positive woman CD4 count &lt; = 400 cells/mm3 . This study also examine body handle Viracept give d4T 3TC .</brief_summary>
	<brief_title>A Study Viracept HIV-Positive Women</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 T cell count &lt; = 400 cells/mm3 . Exclusion Criteria Prior Medication : Excluded : Prior therapy le 1 month therapy d4T and/or 3TC . Prior protease inhibitor therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>Placebos</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>